Screener
West Pharmaceutical Services WST Unrecognized Tax Benefits
Unrecognized Tax Benefits at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's unrecognized tax benefits?
- West Pharmaceutical Services (WST) reported unrecognized tax benefits of $67.5M in Q2 2026.
- What does unrecognized tax benefits mean?
- This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.
Ask your AI about West Pharmaceutical Services's unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude